EarningsQ2 2026 Earnings Report

Rein Therapeutics (015A) Q2 2026 Earnings Report

1 Followers

DE:015A Q2 2026 EPS Results

Actual EPS-€0.09

Consensus EPS-€0.15

Beat/MissBeat by +€0.06

One Year Ago EPS-€0.25

Actual Revenue€0.00

Expected Revenue€0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ2 2026

Date08/14/2026

TimeBefore Open

Conference CallFriday, August 14, 2026

DE:015A Upcoming Earnings

Rein Therapeutics's next earnings date is estimated for November 6, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 06, 2026	2026 (Q3)	-0.09 / -	-0.187	―
Aug 14, 2026	2026 (Q2)	-0.15 / -0.09	-0.25	64.29% (+0.16)
May 20, 2026	2026 (Q1)	- / -	-0.223	―
Apr 06, 2026	2025 (Q4)	-0.44 / -0.17	-0.223	24.00% (+0.05)
Nov 14, 2025	2025 (Q3)	-0.21 / -0.19	-0.241	22.22% (+0.05)
Aug 06, 2025	2025 (Q2)	-0.20 / -0.25	-0.402	37.33% (+0.15)
May 15, 2025	2025 (Q1)	- / -0.22	-0.767	70.93% (+0.54)
Apr 07, 2025	2024 (Q4)	-0.19 / -0.22	-0.767	70.93% (+0.54)
Nov 14, 2024	2024 (Q3)	-0.22 / -0.24	-0.357	32.50% (+0.12)
Aug 14, 2024	2024 (Q2)	-0.20 / -0.40	-0.352	-14.21% (-0.05)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed